The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; BMS; Daiichi Sankyo/Astra Zeneca; Incyte; MSD Oncology; SERVIER
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with resectable pancreatic ductal adenocarcinoma.
 
Nelson J. Dusetti
Stock and Other Ownership Interests - Predicting Med
Patents, Royalties, Other Intellectual Property - PCT/EP2022/065222. Simple transcriptomic signatures to determine chemosensitivity for pancreatic ductal adenocarcinoma. SATT Sud-Est. Inventors: N. Dusetti, N. Fraunhoffer, J. Iovanna, 2021. Licensing to Predicting Med.
 
Nicolas Fraunhoffer
No Relationships to Disclose
 
Pascal Hammel
Consulting or Advisory Role - AstraZeneca (Inst); ERYTECH Pharma (Inst); IPSEN (Inst); Mylan; Rafael Pharmaceuticals; Servier/Pfizer; VECT-HORUS
Speakers' Bureau - AstraZeneca; Mylan; SERVIER
Research Funding - AstraZeneca (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Halozyme; Ipsen; Pfizer/EMD Serono; Shire; Vect-Horus
 
Thierry Conroy
No Relationships to Disclose
 
Remy Nicolle
No Relationships to Disclose
 
Jean-Baptiste Bachet
Honoraria - Amgen; AstraZeneca; Bayer; Merck Serono; MSD Oncology; Pierre Fabre; SERVIER; Viatris
Consulting or Advisory Role - Abbvie; Acobiom; Amgen; Bayer; BMS; GlaxoSmithKline; Incyte; Merck Serono; MSD; Servier
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi; Servier
 
Alexandre Harle
Honoraria - AstraZeneca; Biocartis; GlaxoSmithKline; MSD Oncology; Pierre Fabre; SOPHiA Genetics
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Janssen Oncology; SOPHiA Genetics
 
Vinciane Rebours
No Relationships to Disclose
 
Anthony Turpin
No Relationships to Disclose
 
Meher Ben Abdelghani
Consulting or Advisory Role - Bayer; BMS; Deciphera; Incyte; Merck Serono; Mundipharma; Pierre Fabre; SERVIER; viatris
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER; Viatris
 
Emmanuel Mitry
Honoraria - AstraZeneca/Daiichi Sankyo; Bayer; Esteve; MSD; Pierre Fabre; SERVIER; Viatris
Travel, Accommodations, Expenses - MSD; Pierre Fabre
 
Jim Joseph Biagi
No Relationships to Disclose
 
Brice Chanez
Employment - AstraZeneca; Bristol-Myers Squibb; SERVIER
Leadership - SERVIER
Honoraria - Amgen (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb; SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Pfizer; SERVIER; SERVIER
 
Martin Bigonnet
Employment - Prediciting Med
 
Anthony Lopez
No Relationships to Disclose
 
Ludovic Evesque
No Relationships to Disclose
 
Daniel John Renouf
Honoraria - Bayer; Roche
Consulting or Advisory Role - Bayer; Roche; Viatris
Research Funding - Bayer; Roche (Inst)
 
Marjorie Mauduit
No Relationships to Disclose
 
Jerome Cros
Honoraria - Novartis
Consulting or Advisory Role - HISTALIM
Research Funding - ERYTECH Pharma (Inst)
Travel, Accommodations, Expenses - IPSEN; Novartis
 
Juan Iovanna
Stock and Other Ownership Interests - PanCa therapeutics; PreicitngMed